NCI vs CRAI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
NCI
CRAI
Investment Advisor Scores
CRAI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NCI | CRAI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 20.6612 | Tie |
| PEG Ratio | 1.13 | 1.2926 | NCI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -50.8% | 15.6% | CRAI |
| Earnings Growth | 34.0% | 26.9% | NCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 26.6/100 | 39.5/100 | CRAI |
| Profit Margin | 0.2% | 6.3% | CRAI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NCI
NeutralMixed signals - no dominant trend phase, RSI 65
CRAI
MarkupPrice above SMA50, rising 50-day trend (5.4% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | NCI | CRAI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 21.2 |
| Trailing P/E | — | 25.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | 0.2% |
| Gross Margin | 0.4% | 0.3% |
| Operating Margin | 0.0% | 0.1% |
| EPS | -8.26 | 7.96 |
| Dividend Yield | — | 0.01% |